# Methotrexate With or Without Cyclophosphamide in Treating Patients With Lymphocytic Leukemia

> **NCT00003910** · PHASE2 · TERMINATED · sponsor: **Eastern Cooperative Oncology Group** · enrollment: 59 (actual)

## Conditions studied

- Leukemia

## Interventions

- **DRUG:** Cyclophosphamide
- **DRUG:** Methotrexate
- **DRUG:** Prednisone

## Key facts

- **NCT ID:** NCT00003910
- **Lead sponsor:** Eastern Cooperative Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 1999-09-15
- **Primary completion:** 2010-12-01
- **Final completion:** 2012-03
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2023-07-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003910

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003910, "Methotrexate With or Without Cyclophosphamide in Treating Patients With Lymphocytic Leukemia". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00003910. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*